Artesian Resources (ARTNA) Reaches $38.52 High on Apr, 25; Profile of 1 Analysts Covering ADMA Biologics (ADMA)

The stock of Artesian Resources Corporation (NASDAQ:ARTNA) reached all time high today, Apr, 25 and still has $40.83 target or 6.00% above today’s $38.52 share price. This indicates more upside for the $351.01 million company. This technical setup was reported by Barchart.com. If the $40.83 PT is reached, the company will be worth $21.06 million more. About 17,452 shares traded. Artesian Resources Corporation (NASDAQ:ARTNA) has risen 37.03% since September 16, 2016 and is uptrending. It has outperformed by 26.05% the S&P500.

Among 2 analysts covering ADMA Biologics (NASDAQ:ADMA), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. ADMA Biologics had 5 analyst reports since September 9, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Monday, August 1 by Raymond James. The stock has “Hold” rating by Maxim Group on Monday, August 1. Maxim Group upgraded the stock to “Buy” rating in Monday, January 23 report. The firm has “Buy” rating given on Thursday, September 17 by Maxim Group. Raymond James initiated the shares of ADMA in report on Wednesday, September 9 with “Strong Buy” rating. See ADMA Biologics Inc (NASDAQ:ADMA) latest ratings:

23/01/2017 Broker: Maxim Group Old Rating: Hold New Rating: Buy New Target: $13.00 Upgrade

Investors sentiment decreased to 0.57 in 2016 Q4. Its down 0.18, from 0.75 in 2016Q3. It fall, as 0 investors sold ADMA Biologics Inc shares while 7 reduced holdings. 0 funds opened positions while 4 raised stakes. 7.94 million shares or 1.17% less from 8.03 million shares in 2016Q3 were reported. Iguana Health Mngmt Limited Liability Com stated it has 100,000 shares or 0.31% of all its holdings. Vanguard Gru Inc has 145,394 shares for 0% of their portfolio. Moreover, Geode Management Lc has 0% invested in ADMA Biologics Inc (NASDAQ:ADMA). Prelude Capital Mgmt Limited Liability Co has 0.02% invested in ADMA Biologics Inc (NASDAQ:ADMA). Perceptive Advisors Lc reported 0.26% stake. Consonance Capital Mngmt Lp holds 0.72% or 1.27 million shares in its portfolio. Tower Research Lc (Trc), a New York-based fund reported 785 shares. Spark Invest Mgmt Ltd Liability invested 0.01% in ADMA Biologics Inc (NASDAQ:ADMA). Retail Bank Of America Corporation De has 0% invested in ADMA Biologics Inc (NASDAQ:ADMA) for 1 shares. Broadfin Capital Limited Liability Company has 0.63% invested in ADMA Biologics Inc (NASDAQ:ADMA). Franklin Inc invested in 0% or 359,499 shares. Blackrock Fund stated it has 18,213 shares. Morgan Stanley holds 0% of its portfolio in ADMA Biologics Inc (NASDAQ:ADMA) for 8,237 shares. Weiss Multi stated it has 100,000 shares. Aisling Capital Limited Com owns 3.61M shares or 4.29% of their US portfolio.

About 10,183 shares traded. ADMA Biologics Inc (NASDAQ:ADMA) has declined 23.45% since September 16, 2016 and is downtrending. It has underperformed by 34.43% the S&P500.

ADMA Biologics, Inc. is a late-stage biopharmaceutical firm that develops, makes and intends to market specialty plasma biologics for the treatment and prevention of infectious diseases. The company has market cap of $55.08 million. The Firm is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. It currently has negative earnings. The Company’s divisions include Plasma Collection Centers, which includes its activities in Georgia; Research and Development, which includes its plasma development activities in New Jersey, and Corporate.

Analysts await Artesian Resources Corporation (NASDAQ:ARTNA) to report earnings on May, 3.

Among 2 analysts covering Artesian Resources (NASDAQ:ARTNA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Artesian Resources had 4 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was downgraded by Hilliard Lyons on Wednesday, October 21 to “Underperform”. The firm has “Hold” rating by Zacks given on Friday, August 7. The firm earned “Neutral” rating on Wednesday, March 2 by Robert W. Baird. The stock of Artesian Resources Corporation (NASDAQ:ARTNA) has “Neutral” rating given on Friday, November 6 by Hilliard Lyons.

Investors sentiment increased to 1.32 in 2016 Q4. Its up 0.11, from 1.21 in 2016Q3. It improved, as 3 investors sold Artesian Resources Corporation shares while 22 reduced holdings. 5 funds opened positions while 28 raised stakes. 3.25 million shares or 2.12% less from 3.32 million shares in 2016Q3 were reported. Millennium Mgmt Limited Liability invested 0% of its portfolio in Artesian Resources Corporation (NASDAQ:ARTNA). 31,392 were reported by Parametric Assocs Limited Liability. Fruth Investment Management owns 0.18% invested in Artesian Resources Corporation (NASDAQ:ARTNA) for 12,250 shares. California State Teachers Retirement System reported 0% in Artesian Resources Corporation (NASDAQ:ARTNA). North Star Mngmt Corp has 26,700 shares for 0.13% of their portfolio. Bryn Mawr Trust reported 0.01% stake. 192,170 are held by Dimensional Fund L P. Thrivent Fincl For Lutherans has 74,690 shares for 0.01% of their portfolio. Geode Cap Mgmt Ltd Liability Corp reported 107,378 shares. Metropolitan Life Insurance Communication Ny reported 5,627 shares stake. Blackrock Ltd Liability Corp owns 3,945 shares or 0% of their US portfolio. Ny State Common Retirement Fund reported 0% in Artesian Resources Corporation (NASDAQ:ARTNA). Dalton Greiner Hartman Maher has invested 0.1% in Artesian Resources Corporation (NASDAQ:ARTNA). Royal Bank & Trust Of Canada reported 0% stake. Capital Guardian has invested 0% in Artesian Resources Corporation (NASDAQ:ARTNA).